Form 8-K - Current report:
SEC Accession No. 0001104659-23-059189
Filing Date
2023-05-11
Accepted
2023-05-11 16:45:43
Documents
15
Period of Report
2023-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2315251d1_8k.htm   iXBRL 8-K 33191
2 EXHIBIT 99.1 tm2315251d1_ex99-1.htm EX-99.1 51944
7 GRAPHIC tm2315251d1_ex99-1img003.jpg GRAPHIC 5441
  Complete submission text file 0001104659-23-059189.txt   327128

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gpcr-20230511.xsd EX-101.SCH 3904
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gpcr-20230511_def.xml EX-101.DEF 27410
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gpcr-20230511_lab.xml EX-101.LAB 37323
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gpcr-20230511_pre.xml EX-101.PRE 26032
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2315251d1_8k_htm.xml XML 5987
Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Filer) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41608 | Film No.: 23911810
SIC: 2834 Pharmaceutical Preparations